Header image

Novo Nordisk mini oral: Phenotypic diversity and emerging therapeutic frontiers in heart failure with preserved ejection fraction (HFpEF)

Friday, August 15, 2025
3:15 PM - 3:45 PM
Theatrette 2

Speaker

Agenda Item Image
Prof John Atherton
Director of Cardiology
Royal Brisbane and Women's Hospital

Phenotypic diversity and emerging therapeutic frontiers in heart failure with preserved ejection fraction (HFpEF)

3:15 PM - 3:45 PM

Biography

Prof John Atherton is a Pre-eminent Staff Specialist and Director of Cardiology at the Royal Brisbane and Women’s Hospital (RBWH); Professor, Faculty of Medicine UQ; Adjunct Professor, Faculty of Health, QUT. John Atherton is a Pre-eminent Staff Specialist and Director of Cardiology at the Royal Brisbane and Women’s Hospital (RBWH); Professor, Faculty of Medicine, University of Queensland; Adjunct Professor, Faculty of Health, Queensland University of Technology. Professor Atherton was one of four non-European official content reviewers for the 2016 European Society of Cardiology Heart Failure Guidelines, chaired the 2018 National Heart Foundation of Australia/ Cardiac Society of Australia and New Zealand (CSANZ) Heart Failure Guidelines, and sits on the Therapeutic Guidelines Cardiovascular Expert Group. He recently co-authored the first universal definition of heart failure. Professor Atherton is Data Custodian for the Queensland Cardiac Outcomes Registry (QCOR) - Heart Failure and sits as a Director on the National Cardiac Registry Board. His clinical and research interests include heart failure disease management, investigating the clinical utility of advanced echocardiography, hypertrophic cardiomyopathy and cardiac genetics.
loading